phosphatidylcholines has been researched along with 6-o-palmitoylascorbic acid in 4 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (6-o-palmitoylascorbic acid) | Trials (6-o-palmitoylascorbic acid) | Recent Studies (post-2010) (6-o-palmitoylascorbic acid) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 205 | 6 | 88 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | 6-o-palmitoylascorbic acid (IC50) |
|---|---|---|---|
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 3.1 | |
| Caspase-1 | Homo sapiens (human) | 0.6 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 3.1 | |
| 60 kDa chaperonin | Escherichia coli | 6 | |
| 10 kDa chaperonin | Escherichia coli | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLean, LR; Ohlweiler, DF; Parker, RA; Thomas, CE | 1 |
| Henschke, K; Pietzyk, B | 1 |
| Adikwu, MU; Attama, AA; Ibezim, EC; Nnamani, PO | 1 |
| Chen, Y; Jin, D; Li, L; Liu, Y; Wang, H; Wang, R; Ye, J | 1 |
4 other study(ies) available for phosphatidylcholines and 6-o-palmitoylascorbic acid
| Article | Year |
|---|---|
Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation.
Topics: Antioxidants; Ascorbic Acid; Drug Synergism; Lipid Peroxidation; Liposomes; Oxidation-Reduction; Phenols; Phosphatidylcholines; Probucol; Sulfides; Vitamin E | 1992 |
Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions.
Topics: Antineoplastic Agents; Ascorbic Acid; Carboplatin; Cholesterol; Drug Stability; Drug Storage; Hydrolysis; Liposomes; Particle Size; Pharmaceutical Preparations; Phosphatidylcholines; Temperature; Time Factors | 2000 |
SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats.
Topics: Administration, Oral; Animals; Ascorbic Acid; Blood Glucose; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Carriers; Drug Compounding; Glyburide; Hypoglycemic Agents; Male; Particle Size; Phosphatidylcholines; Rats; Rats, Wistar; Solubility; Technology, Pharmaceutical | 2010 |
Mechanism Study on Nanoparticle Negative Surface Charge Modification by Ascorbyl Palmitate and Its Improvement of Tumor Targeting Ability.
Topics: Ascorbic Acid; Humans; Liposomes; Nanoparticles; Neoplasms; Phosphatidylcholines; RNA, Small Interfering | 2022 |